Medtronic upgraded to Overweight with 3.3% upside to target
Alpha Vantage · Benzinga · · AI-summarised by FinFlash
Top Wall Street analysts have updated their ratings for several companies, with Medtronic plc among them. Piper Sandler analyst Matt O’Brien upgraded Medtronic from Neutral to Overweight, raising its price target. Other companies receiving upgrades include United Natural Foods, Zimmer Biomet Holdings, Nucor Corporation, and Praxis Precision Medicines.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.